PORCN and pancreatic neoplasm: Our previous study showed that a relatively small scale CRISPR library can be faithfully represented in subcutaneous xenografts of HPAF-II cells, a PORCN inhibitor–sensitive RNF43-mutant pancreatic cancer model (18).